Phase II study of the MEK1/MEK2 inhibitor Trametinib in patients with metastatic BRAF-mutant cutaneous melanoma previously treated with or without a BRAF inhibitor (Q36929804)
Jump to navigation
Jump to search
scientific article published on 17 December 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of the MEK1/MEK2 inhibitor Trametinib in patients with metastatic BRAF-mutant cutaneous melanoma previously treated with or without a BRAF inhibitor |
scientific article published on 17 December 2012 |
Statements
1 reference
Phase II study of the MEK1/MEK2 inhibitor Trametinib in patients with metastatic BRAF-mutant cutaneous melanoma previously treated with or without a BRAF inhibitor (English)
1 reference
Antoni Ribas
1 reference
Patrick Hwu
1 reference
Jeffrey A Sosman
1 reference
Michael Millward
1 reference
Daniele Ouellet
1 reference
Kiran Patel
1 reference
Jeffrey R Infante
1 reference
Anna C Pavlick
1 reference
Kevin B Kim
1 reference
Leslie A Fecher
1 reference
Rene Gonzalez
1 reference
Patrick A Ott
1 reference
Olivia S Gardner
1 reference
Yanmei Xu
1 reference
Douglas J DeMarini
1 reference
Ngocdiep T Le
1 reference
Karl D Lewis
1 reference
1 reference
Identifiers
1 reference